Health
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 – DocWire News
EMBO Mol Med. 2021 May 7:e14045. doi: 10.15252/emmm.202114045. Online ahead of print.ABSTRACTThe immune responses and mechanisms limiting symptom
EMBO Mol Med. 2021 May 7:e14045. doi: 10.15252/emmm.202114045. Online ahead of print.
ABSTRACT
The immune responses and mechanisms limiting symptom progression in asymptomatic cases of SARS-CoV-2 infection remain unclear. We comprehensively characterized transcriptomic profiles, cytokine responses, neutralization capacity of antibodies and cellular immune phenotypes of asymptomatic patients with acute SARS-CoV-2 infection to identify potential protective mechanisms. Compared to symptomatic patients,…
-
Business23 hours agoThese ASX 200 shares could rise 50% to 60%
-
General22 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General21 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News23 hours agoQueensland’s film boom: How the Sunshine State is cementing its place as Hollywood’s favourite